INTUITIVE SURG (ISRG) |
Instruments / Accessories – Consensus Forecasts of Instruments / Accessories Revenue in Millions  |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
12/05 |
| $67.8 |
$111.7 |
$191.7 |
$293.1 |
$389.2 |
$540.3 |
$686.6 |
$810.4 |
42.5% |
|
| Systems – Consensus Forecasts of Systems Revenue in Millions |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
12/05 |
| $124.7 |
$205.9 |
$324.3 |
$455.4 |
$488.7 |
$637.6 |
$727.5 |
$843.6 |
31.4% |
|
| Discussion | |
| Last edited Mon Feb 08, 2010 02:20 AM
by SudiptaMukherjee (Zacks Investment Research) |  |
| Products – Consensus Forecasts of Products Revenue in Millions |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
12/05 |
| $192.5 |
$317.6 |
$516.1 |
$748.4 |
$879.7 |
$1,177.9 |
$1,414.2 |
$1,654.1 |
36.0% |
|
| Services – Consensus Forecasts of Services Revenue in Millions |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
12/05 |
| $34.9 |
$55.1 |
$84.7 |
$126.6 |
$172.5 |
$224.6 |
$284.1 |
$345.1 |
38.7% |
|
| Discussion | |
| Last edited Sun Dec 27, 2009 10:40 PM
by SudiptaMukherjee (Zacks Investment Research) | |
EPS FORECASTS
|
This section is designed to find errors as the consensus forecast of EPS. The consensus forecasts for the lines in the INTUITIVE SURG Income Statement are shown and below each consensus forecast is a wiki section to discuss why the consensus forecast of that item may be high or low
|
|
| Consensus Forecasts of Total Revenue |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
12/05 |
| 1. Total Revenue |
$227.4 |
$372.7 |
$600.8 |
$875.0 |
$1,052.0 |
$1,387.1 |
$1,683.9 |
$1,999.2 |
36.4% |
|
| Discussion by Wiki Users | | Intuitive Surgical maintained its FY10 projection for sales growth in a range of 30% to 33% or $1,368 million to $1,399 million. Management reiterated its guidance for over 35% growth in procedures in FY10.
| Last edited Thu Jan 06, 2011 04:51 AM
by MadhubantiMaitra (Zacks Investment Research) | |
| Consensus Forecasts of Fully Diluted Shares Outstanding |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| Fully Diluted Shares Outstanding |
37.5 |
38.1 |
38.9 |
39.8 |
39.1 |
40.8 |
41.9 |
43.5 |
|
| Discussion by Wiki Users | | For FY10, the company expects 40.7 million shares outstanding.
| Last edited Thu Jan 06, 2011 04:52 AM
by MadhubantiMaitra (Zacks Investment Research) | |
| Consensus Forecasts of GAAP EPS |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| GAAP EPS |
$2.5 |
$1.9 |
$3.7 |
$5.1 |
$5.9 |
$8.3 |
$10.4 |
|
|
| Consensus Forecasts of Cost of Goods Sold |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| 2. Cost of Goods Sold |
$73.8 |
$124.5 |
$186.2 |
$253.4 |
$301.1 |
$384.3 |
$465.0 |
$536.1 |
| Percent of Revenue |
32% |
33% |
31% |
29% |
29% |
28% |
28% |
27% |
| 3. Gross Profit (1-2) |
$153.60 |
$248.20 |
$414.60 |
$621.60 |
$750.90 |
$1,002.80 |
$1,218.90 |
$1,463.10 |
| Percent of Revenue |
68% |
67% |
69% |
71% |
71% |
72% |
72% |
73% |
|
| Consensus Forecasts of Selling, General and Administrative Expense |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| 4. Selling, General and Administrative Expense |
$67.4 |
$109.4 |
$158.7 |
$230.6 |
$278.6 |
$357.7 |
$425.8 |
$498.4 |
| Percent of Revenue |
30% |
29% |
26% |
26% |
26% |
26% |
25% |
25% |
|
| Discussion by Wiki Users | | Growth in operating expenses is now estimated in a range of 27% to 29% y/y for FY10 (up from 25% earlier).
| Last edited Thu Jan 06, 2011 04:53 AM
by MadhubantiMaitra (Zacks Investment Research) | |
| Consensus Forecasts of Research and Development |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| 5. Research and Development |
$17.4 |
$29.4 |
$48.9 |
$79.4 |
$95.1 |
$120.7 |
$146.1 |
$174.9 |
| Percent of Revenue |
8% |
8% |
8% |
9% |
9% |
9% |
9% |
9% |
|
| Consensus Forecasts of Interest Income/(Expense) |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| 6. Interest Income/(Expense) |
$5.0 |
$12.7 |
$24.5 |
$23.7 |
$18.8 |
$18.1 |
$25.4 |
$31.5 |
| Percent of Revenue |
2% |
3% |
4% |
3% |
2% |
1% |
2% |
2% |
|
| Consensus Forecasts of Pre - Tax Income |
| |
Dec-05 |
Dec-06 |
Dec-07 |
Dec-08 |
Dec-09 |
Dec-10 |
Dec-11 |
Dec-12 |
| 7. Pre - Tax Income(3-4-5-6) |
$63.80 |
$96.70 |
$182.50 |
$287.90 |
$358.40 |
$506.30 |
$621.60 |
$758.30 |
| 8. Tax provisions |
$6.0 |
$48.1 |
$90.3 |
$130.7 |
$163.4 |
$198.7 |
$243.8 |
$291.6 |
| Percent of Revenue |
9% |
50% |
49% |
45% |
46% |
39% |
39% |
38% |
| 9. Net Income (7-8) |
$57.80 |
$48.60 |
$92.20 |
$157.20 |
$195.00 |
$307.60 |
$377.80 |
$466.70 |
|
| Discussion by Wiki Users | |
| Last edited Mon Feb 08, 2010 02:22 AM
by SudiptaMukherjee (Zacks Investment Research) | |
| ISRG (INTUITIVE SURG) |
$1,192.00 |
$289.76 |
19.4% |
25% |
38.02 |
10.6 |
44.4 |
Industry Mean |
|
|
-1% |
21% |
25.63 |
8.2 |
20.0 |
| S&P 500 |
|
|
23% |
11% |
13.71
| 1.9 |
|
|
|
|
|
|
|
|
|
IDXX (IDEXX LABS INC) |
$1,064.00 |
$129.18 |
26.1% |
19% |
27.89 |
3.4 |
21.2 |
HOLX (HOLOGIC INC) |
$1,636.00 |
$122.65 |
11.3% |
11% |
12.62 |
2.3 |
1.3 |
VAR (VARIAN MEDICAL) |
$2,278.00 |
$352.30 |
26.7% |
16% |
17.39 |
2.7 |
16.6 |
CF is operating cash flow plus after-tax interest expense. |
|
| Discussion of Relative Valuation | | No comments yet. Be the first | | |
|
|
| | |
Created by: WikiMigrationBot.
Last Modification: Thursday 03 of June, 2010 07:33:15 CDT by anups@zacksindia.com.
|
